Cortrosyn
Cortrosyn (cosyntropin) 0.25 mg Injection, USP 1ml Vial
Approved
Approval ID
0c424fac-b114-41f6-aba8-cf710a34c26c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 19, 2024
Manufacturers
FDA
Henry Schein, Inc.
DUNS: 012430880
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cortrosyn
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0404-9839
Application NumberNDA016750
Product Classification
M
Marketing Category
C73594
G
Generic Name
Cortrosyn
Product Specifications
Route of AdministrationPARENTERAL, INTRAVENOUS, INTRAMUSCULAR
Effective DateJanuary 9, 2022
FDA Product Classification
INGREDIENTS (1)
CosyntropinActive
Quantity: 0.25 mg in 1 mL
Code: 72YY86EA29
Classification: ACTIB